#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2189097	F	Growth inhibition of human A549 cells	Homo sapiens	33	ALA2177013	cell-based format	Scientific Literature
2.	ALA2189098	F	Growth inhibition of human HepG2 cells	Homo sapiens	33	ALA2177013	cell-based format	Scientific Literature
3.	ALA2182909	A	Oral bioavailability in Sprague-Dawley rat at 3 mg/kg by HPLC-MS method	Rattus norvegicus	5	ALA2177013	organism-based format	Scientific Literature
4.	ALA2182910	A	AUC (0 to infinity) in Sprague-Dawley rat at 3 mg/kg, po by HPLC-MS method	Rattus norvegicus	3	ALA2177013	organism-based format	Scientific Literature
5.	ALA2182913	A	Tmax in Sprague-Dawley rat at 3 mg/kg, po by HPLC-MS method	Rattus norvegicus	3	ALA2177013	organism-based format	Scientific Literature
6.	ALA2182915	A	Cmax in Sprague-Dawley rat at 3 mg/kg, po by HPLC-MS method	Rattus norvegicus	3	ALA2177013	organism-based format	Scientific Literature
7.	ALA2182916	A	Apparent elimination half life in Sprague-Dawley rat at 3 mg/kg, po by HPLC-MS method	Rattus norvegicus	3	ALA2177013	organism-based format	Scientific Literature
8.	ALA2182919	A	AUC (0 to infinity) in Sprague-Dawley rat at 3 mg/kg, iv by HPLC-MS method	Rattus norvegicus	3	ALA2177013	organism-based format	Scientific Literature
9.	ALA2182921	A	Volume of distribution at steady state in Sprague-Dawley rat at 3 mg/kg, iv by HPLC-MS method	Rattus norvegicus	3	ALA2177013	organism-based format	Scientific Literature
10.	ALA2182922	A	Clearance in Sprague-Dawley rat at 3 mg/kg, iv by HPLC-MS method	Rattus norvegicus	3	ALA2177013	organism-based format	Scientific Literature
11.	ALA2182925	A	Apparent elimination half life in Sprague-Dawley rat at 3 mg/kg, iv by HPLC-MS method	Rattus norvegicus	3	ALA2177013	organism-based format	Scientific Literature
12.	ALA2183308	F	Antiviral activity against Transmissible gastroenteritis virus infected in ST cells assessed as reduction in caspase-3 activation pre-treated before virus infection measured 16 hrs post virus infection by Western blotting	Transmissible gastroenteritis virus	6	ALA2177013	organism-based format	Scientific Literature
13.	ALA2183309	F	Antiviral activity against Transmissible gastroenteritis virus infected in ST cells assessed as reduction in N-protein expression pre-treated before virus infection measured 16 hrs post virus infection by Western blotting	Transmissible gastroenteritis virus	6	ALA2177013	organism-based format	Scientific Literature
14.	ALA2183310	F	Reduction in LPS/INFgamma-induced COX2 protein expression in mouse RAW264.7 cells incubated for 20 hrs by Western blotting	Mus musculus	6	ALA2177013	cell-based format	Scientific Literature
15.	ALA2183311	F	Reduction in LPS/INFgamma-induced iNOS protein expression in mouse RAW264.7 cells incubated for 20 hrs by Western blotting	Mus musculus	6	ALA2177013	cell-based format	Scientific Literature
16.	ALA2183312	F	Induction of c-Jun protein accumulation in human A549 cells incubated for 24 hrs by Western blotting	Homo sapiens	6	ALA2177013	cell-based format	Scientific Literature
17.	ALA2183313	F	Down regulation of cyclin A2 expression in human A549 cells incubated for 24 hrs by Western blotting	Homo sapiens	6	ALA2177013	cell-based format	Scientific Literature
18.	ALA2183314	F	Induction of c-Jun protein accumulation in human NCI-H460 cells incubated for 24 hrs by Western blotting	Homo sapiens	6	ALA2177013	cell-based format	Scientific Literature
19.	ALA2183315	F	Down regulation of cyclin A2 expression in human NCI-H460 cells incubated for 24 hrs by Western blotting	Homo sapiens	6	ALA2177013	cell-based format	Scientific Literature
20.	ALA2183316	F	Induction of c-Jun protein accumulation in human MCF7 cells incubated for 24 hrs by Western blotting	Homo sapiens	6	ALA2177013	cell-based format	Scientific Literature